腹腔镜联合药物治疗多囊卵巢综合征50例疗效观察被引量：1

Preliminary Study of Curative Effect of Electro Coagulation Unde Laparoswpe Plus Drugs in 50 Polyycystic Ovarian Syndrome

下载PDF

导出

摘要目的:观察腹腔镜联合药物二甲双胍及氯米酚与二甲双胍及氯米酚治疗多囊卵巢综合征(PCO S)疗效比较。方法:对确诊为PCO S患者随机分成两组:研究组(n=50例)采用腹腔镜联合药物治疗;对照组(n=45例)采用药物治疗。疗程半年,治疗前后抽血查黄体生成素(LH)、卵泡刺激素(FSH)、睾酮(T)、雌二醇(E2)及空腹血糖(FG)、空腹胰岛素(F ins),观察月经、排卵、妊娠情况。结果:在以上6种指标中,LH、T、F ins治疗前后差异有显著(P<0.01),FSH、E2、FG差异无显著(P>0.05),两组比较月经恢复及排卵情况差异无显著(P>0.05),但妊娠率差异有显著(P<0.01)。结论:两组比较在改善月经、排卵等方面作用相似,但腹腔镜联合药物组妊娠率高些。

作者李辉宋小婕

机构地区武汉市商业职工医院妇产科

出处《数理医药学杂志》 2006年第3期255-256,共2页 Journal of Mathematical Medicine

关键词腹腔镜联合药物多囊卵巢综合征疗效

分类号 R711.75 [医药卫生—妇产科学]

引文网络
相关文献

参考文献7

1丰有吉主编..妇产科学[M].北京:人民卫生出版社,2002:493.
2范燕宏,陈贵安.多囊卵巢综合征与不孕[J].实用妇产科杂志,2005,21(8):455-456. 被引量：23
3李国华,黄薇.二甲双胍在多囊卵巢综合征的应用[J].实用妇产科杂志,2005,21(9):534-537. 被引量：34
4郑建淮,曹缵孙,陈晓燕,杨卉,毛文军.二甲双胍对多囊卵巢综合征伴胰岛素抵抗患者的作用[J].西安交通大学学报（医学版）,2003,24(2):160-163. 被引量：10
5Laurel A,BenjaminC,OehninyerWS.Should patients with polycystic ovary syndrome be treated with metformin Benefits of insusin sensitizing drags in polycystic ovary syndrome-beyond ovulationb indue.Human Reproduction,2002,17:3016～ 3025. 被引量：1
6Attia CR,Rainey WE,CarrBR.Metformin directly inhibits androgen production in human thecal cells,Fertility and Sterility,2001,76:517～522. 被引量：1
7任慕兰,赵维英,蔡云朗,何丽萍.腹腔镜卵巢电凝术治疗难治性多囊卵巢综合征的临床研究[J].中国微创外科杂志,2003,3(2):114-115. 被引量：22

二级参考文献20

1Wu XK,Zhou SY,Sallinen,et al.Ovarian selective resistance to insulin signaling in the polycystic ovary syndrome.Fertil Steril,2003,80(4):954～965. 被引量：1
2Karen ER,Evelyn OT,Jeanne VZ,et al.Evidence for competing effects of body mass,hyperinsulinemia,insulin resistance,and androgen on leptin levels among lean,overweight and obese women with polycystic syndrome.Fertil Steril,2002,78(3):479～486. 被引量：1
3Macial GA,Soares JM,Alves El,et al.Nonobese women with polycystic ovary syndrome respond better than obese women to treatment with metformin.Fertil Steril,2004,81(2):355～360. 被引量：1
4Glueck CJ,Goldenberg N,Pranikoff J,et al.Height,weight,and motor-social development during the first 18 months of lifes in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy.Hum Reprod,2004,19(6):1323～1330. 被引量：1
5Genazzani AD,Battaglia C,Malavasi B,et al.Metformin administration medolates and restore luteining hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome.Fetil Steril,2004,81(1):114～119. 被引量：1
6Gleuck CJ,Wang P,Fontaine R,et al.Metformin to Restore Normal Menses in Oligo-Amenorrheic Teenage Girls With Polycystic Ovary Syndrome (PCOS).J Adol Health,2001,29(3):160～169. 被引量：1
7Kolodziejczyk B,Duleba AJ,Spaczynski RZ,et al.Metformin therapy decreases hyperandrogenism and hyperinsulinemia in women with polycystic ovary syndrome.Fertil Steril,2000,73(6):1149～1154. 被引量：1
8Laure C,Morin-Papunen,Ilkka V,et al.Endocrine and metabolic effect of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome:a randomized study.J.Clin.Endocrinol.Metab,2000,85(9):3161～3168. 被引量：1
9Morin-Papunen L,Vauhkonen I,Koivunen R,et al.Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome:a randomized study.J Clin.Endocrinol.Metab,2003,88(1):148～156. 被引量：1
10Elter K,Imir G,Durmusoglu F.Clinical,endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome:a randomized controlled study.Hum Reprod,2002,17(7):1729～1737. 被引量：1